Matched-pair analysis of [(177)Lu]Lu-PSMA I&T and [(177)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

BACKGROUND: Labelled with lutetium-177, the urea-based small molecules PSMA I&T and PSMA-617 are the two agents most frequently used for radioligand therapy (RLT) in patients with advanced metastatic castration-resistant and prostate-specific membrane antigen (PSMA) expressing prostate cancer (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartrampf, Philipp E., Weinzierl, Franz-Xaver, Buck, Andreas K., Rowe, Steven P., Higuchi, Takahiro, Seitz, Anna Katharina, Kübler, Hubert, Schirbel, Andreas, Essler, Markus, Bundschuh, Ralph A., Werner, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250457/
https://www.ncbi.nlm.nih.gov/pubmed/35243517
http://dx.doi.org/10.1007/s00259-022-05744-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250457/
https://www.ncbi.nlm.nih.gov/pubmed/35243517
http://dx.doi.org/10.1007/s00259-022-05744-6

Ejemplares similares